🇺🇸 FDA
Patent

US 9056891

Synthetic peptide inhibitors of Wnt pathway

granted A61KA61K38/00

Quick answer

US patent 9056891 (Synthetic peptide inhibitors of Wnt pathway) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/00